Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Cell Culture The World Market for Media, Sera, and Reagents |
Jan 2007 | £2,465 | 100% |
| Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel) |
Nov 2007 | £2,215 | 99% |
| Clinical Cell Culture Limited Product Pipeline Analysis | Jan 2009 | £475 | 99% |
| Biomarkers: A Market Briefing A Market Briefing |
Jan 2007 | £1,260 | 99% |
| Outsourcing in Drug Development The Contract Research (Clinical Trial ) Market |
Jan 2012 | £2,525 | 98% |
| Emerging Market for Clinical Trials in Poland Cost Advantages of Nearly 30% as Compared to the US |
Dec 2011 | £2,215 | 98% |
| SyntheMed, Inc. Product Pipeline Analysis | Jan 2009 | £475 | 98% |
| Dyskinesia Therapeutics Pipeline Assessment and Market Forecasts to 2019 |
Dec 2011 | £2,215 | 98% |
| Clinical Trials Business; The | Jan 2006 | £2,760 | 98% |
| Angiotech Pharmaceuticals, Inc. Product Pipeline Analysis | Aug 2008 | £475 | 97% |
| Thoratec Corporation Product Pipeline Analysis | Jan 2009 | £475 | 97% |
| Pipeline Insight: Epilepsy Pipeline drugs struggle to outshine their marketed predecessors |
Oct 2006 | £7,210 | 97% |
| Vitiligo Therapeutics Pipeline Assessment and Market Forecasts to 2019 |
Jan 2012 | £2,525 | 97% |
| Global Clinical Trial Business Report & Analysis 20082018 | Jul 2008 | £1,499 | 96% |
| U.S. CRO Markets - Key Therapeutic Areas | Jul 2009 | £3,795 | 96% |
| Accelerating Patient Recruitment in Clinical Trials | Jul 2006 | £75 | 96% |
| R&D Trends: Bipolar Disorder Developments in schizophrenia dictate trends in diminutive bipolar disorders pipeline |
Apr 2011 | £2,405 | 96% |
| Pharmaceutical Partnership Deal Terminations | Sep 2011 | £2,215 | 96% |
| Male Hypogonadism Therapeutics Pipeline Assessment and Market Forecasts to 2019 |
Dec 2011 | £2,215 | 96% |
| Paradigm Spine, LLC Product Pipeline Analysis | Jan 2009 | £475 | 96% |
| Lenstec, Inc. Product Pipeline Analysis | Jan 2009 | £475 | 96% |
| Clinical trials in Poland 2010 Development forecasts for 2010-2012 |
Apr 2010 | £1,660 | 96% |
| Myasthenia Gravis Therapeutics Pipeline Assessment and Market Forecasts to 2019 |
Jan 2012 | £2,525 | 96% |
| Overactive Bladder (OAB) Therapeutics Pipeline Assessment and Market Forecasts to 2019 |
Jan 2012 | £2,525 | 96% |
| Trends in Clinical Trials: Strategies to Enhance Clinical Trial Design | Sep 2008 | £2,405 | 96% |
| Terumo Corporation Product Pipeline Analysis | Jan 2009 | £475 | 96% |
| Ankylosing Spondylitis Therapeutics Pipeline Assessment and Market Forecasts to 2019 |
Jan 2012 | £2,525 | 95% |
| Pipeline Insight: Breakthrough Pain Fast-acting players will capture majority market share |
Nov 2006 | £7,210 | 95% |
| Oncolytics Biotech Inc. – Product Pipeline Review H2 2011 |
Oct 2011 | £315 | 95% |
| Pharma Clinical Trial Services World Market 2011-2021 |
Jul 2011 | £1,499 | 95% |
